Hypoxia-inducible factor 1a is a Tsc1-regulated survival factor in newborn neurons in tuberous sclerosis complex

David M Feliciano1, Shiliang Zhang, Jennifer L Quon

  • 1Department of Neurosurgery, Yale University School of Medicine, New Haven, CT, USA.

Human Molecular Genetics
|January 26, 2013
PubMed

Insights

Tuberous sclerosis complex (TSC) involves brain lesions with misplaced neurons. This study shows hypoxia-inducible factor 1a (HIF1a) is upregulated in TSC neurons, promoting their survival.

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Tuberous sclerosis complex (TSC) is a genetic disorder linked to TSC1/TSC2 mutations.
  • TSC causes hyperactivity of the mammalian target of rapamycin (mTOR) pathway.
  • Brain lesions in TSC contain misplaced neurons with high levels of hypoxia-inducible factor 1a (HIF1a).

Purpose of the Study:

  • To investigate the relationship between TSC1/2 and HIF1a.
  • To determine the function of HIF1a in neurons affected by TSC.
  • To explore the role of HIF1a in the survival of misplaced neurons in a mouse model of TSC.

Main Methods:

  • Utilized single-cell electroporation in the subventricular zone (SVZ) of neonatal mice to delete Tsc1.
  • Generated olfactory bulb lesions containing Tsc1-null neurons.
  • Assessed HIF1a transcriptional activity and neuron survival using shRNA and dominant-negative constructs.

Main Results:

  • Tsc1-null neurons exhibited elevated HIF1a transcriptional activity compared to controls.
  • These neurons showed resistance to HIF1a antagonist-induced cell death.
  • Knockdown of Hif1a led to significant loss (80-90%) of Tsc1-null newborn neurons, sparing stem cells.

Conclusions:

  • HIF1a is crucial for the survival of newborn neurons in the context of TSC.
  • Upregulation of HIF1a, dependent on TSC1, confers a survival advantage to Tsc1-null neurons.
  • HIF1a plays a key role in the adaptation and survival of misplaced neurons within TSC-associated lesions.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Hypoxia01:23

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...